Division of General Surgery and Bariatric Centre of Excellence, Department of Medical-Surgical Sciences and Biotechnologies, University of Rome "La Sapienza", Rome, Italy.
Surg Endosc. 2019 Nov;33(11):3783-3789. doi: 10.1007/s00464-019-06676-3. Epub 2019 Jan 23.
The aim of the present paper is to report the results of a single institution series of hiatal hernia repair (HHR) with augmented mesh hiatoplasty focusing on safety and efficacy profile of Bio-A absorbable synthetic mesh.
A retrospective evaluation of prospectively maintained database showed 120 consecutive patients submitted to HHR reinforced with bio-absorbable synthetic mesh. The study populations included two groups: (A) 92 obese patients-reinforced hiatoplasty concurrent with bariatric procedure; (B) 28 non-obese patients-reinforced hiatoplasty concurrent with antireflux surgery. Symptoms assessment was made with GERD-HRQL and Rome III. The X-ray with barium swallow, the CT scan, in selected cases, and the endoscopy were used as recurrence evaluation and as endoscopic complications assessment. Only patients with a mean follow-up of 12 months were included in this study. A Cox hazard was made to evaluate factors affecting the recurrence.
No case of intra-peri and post-operative (mean follow-up of 41 months) complications mesh related were registered. The dysphagia-rate was 8.7% for Group A and 11% for Group B. 74% of Group A and 61% of Group B patients are actually PPIs free with median GERD-HRQL score of 4 (from 16) and 6 (from 23), respectively (difference pre-post-operative < 0.05). Recurrence rate was 5.4% in Group A and 7.1% in Group B. The Cox hazard analysis showed that the use of more than four stitches for cruroplasty represents a negative factor on recurrence (HR = 8; p < 0.05).
This is, in our knowledge, the largest report (120 consecutive patients) with mid-term follow-up (41 months of mean FU) on bio-absorbable mesh on the hiatus in obese and non-obese patients. These results supports the use of absorbable mesh for HHR (safe profile-0% of complications rate), showing excellent recurrence rate results and good GERD symptoms control.
本文旨在报告单中心系列食管裂孔疝修补术(HHR)的结果,重点介绍增强型网片膈成形术在生物可吸收合成网片的安全性和疗效。
对前瞻性维护的数据库进行回顾性评估,显示 120 例连续接受生物可吸收合成网片增强 HHR 的患者。研究人群包括两组:(A)92 例肥胖患者-膈成形术与减重手术同时进行;(B)28 例非肥胖患者-膈成形术与抗反流手术同时进行。症状评估采用 GERD-HRQL 和罗马 III。X 射线钡餐、CT 扫描(在某些情况下)和内镜用于评估复发和内镜并发症。本研究仅纳入平均随访 12 个月以上的患者。采用 Cox 风险评估复发的影响因素。
未发生与术中及术后(平均随访 41 个月)相关的网片相关并发症。A 组吞咽困难发生率为 8.7%,B 组为 11%。A 组 74%和 B 组 61%的患者目前无需使用质子泵抑制剂,中位 GERD-HRQL 评分分别为 4(16 分)和 6(23 分)(术前术后差异<0.05)。A 组复发率为 5.4%,B 组为 7.1%。Cox 风险分析显示,膈成型术中使用超过四针缝线是复发的负性因素(HR=8;p<0.05)。
这是我们所知的关于生物可吸收网片在肥胖和非肥胖患者食管裂孔疝中的最大报告(120 例连续患者),随访时间为 41 个月。这些结果支持使用可吸收网片进行 HHR(安全,无并发症发生率为 0%),复发率结果优异,胃食管反流病症状控制良好。